32nd EURORDIS Round Table of Companies Workshop
Get ready for imminent changes!
The impact of the EU regulatory network strategy 2020-2025 on the development of orphan medicines in a rapidly evolving healthcare environment
20-21 October 2021 (14:00-18:00 CET)
The European Medicines Agencies Network Strategy to 2025 and Regulatory Science Strategy to 2025 are forming a comprehensive approach to plan and prepare for the future. This includes preparing the EU regulatory network for the next generation of regulatory activities. In order to do this, four EMA Task Forces have been created on: Digital Business Transformation, Data Analytics and Methods, Regulatory Science & Innovation and Clinical Studies and Manufacturing.
The 32nd EURORDIS Round Table of Companies Workshop will place a strong emphasis on exploring and discussing elements of these task forces, and their impact and importance for developers of rare disease treatments.
This is your opportunity to join us to discuss and gain insights into new methods to analyse data, new sources of data and changes in the way new Clinical Trials are conducted (learn more).
Fill out the form below to register for the workshop.